Technology and Health Communication in Improving Health Outcomes in Patients Scheduled for Mammography
NCT ID: NCT04290585
Last Updated: 2020-03-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
160 participants
INTERVENTIONAL
2014-03-05
2017-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Trial of a Mammography Decision Aid for Women Aged 75 and Older
NCT02198690
A Mammography FastTrack Program in Increasing the Number of Women Undergoing Breast Cancer Screening
NCT00462891
Communicating Objective Risk for Personalized Decision Making About Mammography
NCT01686360
Evaluating Mammography Communication Approaches
NCT07228234
Automated Tele Counseling for Screening Mammography
NCT00247013
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. To decrease the mobile mammography unit no-show rate by sending text message appointment reminders to patients.
II. To assess the efficacy of the text message reminders at addressing the no-show rate by collecting satisfaction survey data from patients that received the texts and that came to their scheduled appointment.
OUTLINE:
Patients receive 1-2 text messages a few weeks before and 1 text message 24 hours before their mammography screening appointment. Patients also receive a phone call reminder as per standard practice.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Health Services Research (text message reminder)
Patients receive 1-2 text messages a few weeks before and 1 text message 24 hours before their mammography screening appointment. Patients also receive a phone call reminder as per standard practice.
Questionnaire Administration
Ancillary studies
Telephone-Based Intervention
Receive text message reminders
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaire Administration
Ancillary studies
Telephone-Based Intervention
Receive text message reminders
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Has a cell phone that can send and receive text messages
* Agrees to receive the text messages
* Can read either English or Spanish
* Not yet sent text messages to 100 patients in community or corporate sites
* Scheduled at least 1 week prior to the appointment date
* PATIENTS FOR FOLLOW UP: come to their scheduled appointment
* PATIENTS FOR FOLLOW UP: received the text message reminders
* PATIENTS FOR FOLLOW UP: can read either English or Spanish
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
Fox Chase Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nestor Esnaola
Role: PRINCIPAL_INVESTIGATOR
Fox Chase Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2015-02088
Identifier Type: REGISTRY
Identifier Source: secondary_id
IRB13858
Identifier Type: OTHER
Identifier Source: secondary_id
IRB13858
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.